First Time Loading...

Agiliti Inc
NYSE:AGTI

Watchlist Manager
Agiliti Inc Logo
Agiliti Inc
NYSE:AGTI
Watchlist
Price: 10.07 USD 0.3% Market Closed
Updated: Apr 24, 2024

ROE
Return on Equity

-2.1%
Current
1%
Average
3.1%
Industry
Negative for the last year
-2.1%
Positive average
1%
Worse than average
Worse than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
-2.1%
=
Net Income
-19.4m
/
Equity
943.8m

ROE Across Competitors

ROE Comparison
Agiliti Inc Competitors

Country Company Market Cap ROE
US
Agiliti Inc
NYSE:AGTI
1.4B USD
-2%
US
Cigna Group
XMUN:CGN
96.4B EUR
11%
US
Cigna Corp
NYSE:CI
102.9B USD
11%
US
CVS Health Corp
NYSE:CVS
87.5B USD
11%
DE
Fresenius Medical Care AG
XMUN:FME
22.9B EUR
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.4B USD
5%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.4B EUR
-3%
US
Quest Diagnostics Inc
NYSE:DGX
15.3B USD
14%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR
4%
US
DaVita Inc
NYSE:DVA
11.9B USD
78%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
Agiliti Inc
NYSE:AGTI
Country US
Market Cap 1.4B USD
ROE
-2%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 96.4B EUR
ROE
11%
Cigna Corp
NYSE:CI
Country US
Market Cap 102.9B USD
ROE
11%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 87.5B USD
ROE
11%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 22.9B EUR
ROE
4%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 17.4B USD
ROE
5%
F
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 15.4B EUR
ROE
-3%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 15.3B USD
ROE
14%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 11.4B EUR
ROE
4%
DaVita Inc
NYSE:DVA
Country US
Market Cap 11.9B USD
ROE
78%
Oak Street Health Inc
NYSE:OSH
Country US
Market Cap 9.5B USD
ROE
464%

Profitability Report

View the profitability report to see the full profitability analysis for Agiliti Inc.

Full Profitability Report

See Also

Summary
AGTI intrinsic value, competitors valuation, and company profile.
DCF Valuation
AGTI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AGTI stock valuation using valuation multiples.
Wall Street Estimates
AGTI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AGTI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
-2.1%
=
Net Income
-19.4m
/
Equity
943.8m
What is the ROE of Agiliti Inc?

Based on Agiliti Inc's most recent financial statements, the company has ROE of -2.1%.

ALPHA SPREAD
Join more than 131,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.